📰 Ichnos Sciences Inc News
Ichnos Sciences Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ichnos Sciences Inc. Real-time updates on events, politics, business and more.
January 31, 2024
(This story has not been edited by THE WEEK and is auto-generated from a PTI
January 31, 2024
Glenmark Pharmaceuticals Ltd , a leading, research-driven, global pharmaceutical company, and Ichnos Sciences...
January 30, 2024
Glenmark Pharmaceuticals and Ichnos Sciences have formed an alliance called Ichnos Glenmark Innovation (IGI) to accelerate cancer drug discovery. The alliance combines Glenmarks expertise in small molecules with Ichnos proficiency in novel biologics. They are developing therapy solutions for hematological malignancies and solid tumors, with three innovative oncology molecules currently in clinical trials.
January 30, 2024
This alliance brings together drug innovation capabilities of Ichnos and Glenmark to develop cutting-edge therapies for the treatment of hematological...
January 30, 2024
Get latest articles and stories on Latest News at LatestLY. Glenmark Pharmaceuticals Ltd and Ichnos Sciences Inc announced an alliance to accelerate new drug discovery in cancer treatment. Latest News | Glenmark, Ichnos Sciences Form Alliance for New Drug Discovery in Cancer Treatment.
January 30, 2024
IGI is introducing a pipeline of three oncology molecules currently undergoing clinical trials, targeting multiple myeloma, acute myeloid leukemia, and solid tumors.
October 3, 2023
/PRNewswire/ -- Ichnos Sciences Inc., a global clinical-stage biotechnology company developing innovative multispecific antibodies for oncology, today...
June 26, 2023
NEW YORK, June 26, 2023 /PRNewswire/ -- Ichnos Sciences Inc., a global clinical-stage biotechnology company developing innovative multispecific an...
March 21, 2023
/PRNewswire/ -- Ichnos Sciences Inc., a global clinical-stage biotechnology company developing innovative multispecific antibodies in oncology, today announced...
December 12, 2022
/PRNewswire/ -- Ichnos Sciences Inc., a global clinical-stage biotechnology company developing innovative multispecific immune cell engager antibodies in...